Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.750
+0.050 (1.06%)
At close: Jun 26, 2026, 4:00 PM EDT
4.750
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
Lexeo Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Lexeo Therapeutics stock have an average target of 17.13, with a low estimate of 9.00 and a high estimate of 25. The average target predicts an increase of 260.63% from the current stock price of 4.75.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Lexeo Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 8 | 8 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $12 → $9 | Buy | Maintains | $12 → $9 | +89.47% | Jun 25, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $17 | Buy | Maintains | $17 | +257.89% | May 12, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $20 | Buy | Maintains | $20 | +321.05% | May 12, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +257.89% | May 11, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $20 | Buy | Reiterates | $20 | +321.05% | Mar 31, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
6.88M
EPS This Year
-1.14
from -1.93
EPS Next Year
-1.24
from -1.14
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 55.0M | |
| Avg | n/a | 6.9M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 2,577.0% |
| Avg | - | 1,212.1% |
| Low | - | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.99 | -0.85 | |
| Avg | -1.14 | -1.24 | |
| Low | -1.28 | -1.70 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.